News

MULTIMEDIA: Vemurafenib -- Melanoma Drug Cuts Death Risk

Publish date: August 10, 2011
By
Therese Borden

 

This drug works by attacking a specific genetic mutation, BRAF V600E, that accelerates tumor growth.

<a href="http://storify.com/taborden/vemurafenib-gives-melanoma-patients-new-hope" target="_blank">View "Vemurafenib" on Storify</a>

Recommended Reading

Obesity, Estrogen Status Influence Breast Cancer Outcomes
MDedge Internal Medicine
Triptorelin Cuts Early Menopause in Breast Cancer
MDedge Internal Medicine
Intensified Temozolomide Fails to Hike Glioblastoma Survival
MDedge Internal Medicine
Mutations Linked to Esophageal Adenocarcinoma, Barrett's Esophagus
MDedge Internal Medicine
Occult Sentinel Node Metastases Don't Impact Survival
MDedge Internal Medicine
Stereotactic Radiation Gives Elderly Lung Cancer Patients an Alternative to Surgery
MDedge Internal Medicine
ASCO Calls for Oncology-Based Medical Homes
MDedge Internal Medicine
CAD Software Does Not Improve Mammogram Accuracy
MDedge Internal Medicine
Paraneoplastic Autoimmune Multiorgan Syndrome Proves Rapidly Fatal
MDedge Internal Medicine
Platinum-Based Chemotherapy Benefits Elderly Lung Cancer Patients
MDedge Internal Medicine

Related Articles